Acadia’s Nuplazid Needs Another Study For Alzheimer’s Psychosis, US FDA Panel Says

Truck blocking road
For Nuplazid to add an indication in Alzheimer's psychosis, there is no way around conducting another study, an FDA panel member said. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers